Zhejiang Jingxin Pharmaceutical Co Ltd002020
▲ PositiveCapitalrelevance
Company repurchased shares, indicating management confidence and supporting stock price.

Jingxin Pharmaceutical announced that as of July 31, 2026, the company had repurchased 1.01 million shares, accounting for 0.12% of total share capital. The repurchase transaction price range was 13.45 yuan to 14.14 yuan per share, and the total repurchase amount was 13.85 million yuan. In the first quarter of 2026, the company achieved revenue of 923 million yuan and net profit attributable to the parent company of 165 million yuan.
Zhejiang Jingxin Pharmaceutical Co LtdCompany repurchased shares, indicating management confidence and supporting stock price.